Company Overview and News

 
Tencent, Cnooc to Join Hang Seng China Index in Major Revamp - Bloomberg

2018-02-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Insider share buys hint at upside for L’Occitane International, Guangdong Investment and Shun Tak Holdings

2017-11-26 scmp
Buying rose for the third straight week as 58 companies recorded 329 purchases worth HK$580 million (US$74.29 million)

 
Two decades on, Hong Kong’s stock market sees China everywhere

2017-06-29 scmp
Twenty years ago, when Hong Kong waved farewell to Britain’s 156 years of colonial rule, the city’s stock market was still in a bubble fuelled by rising household wealth and inflows of hot money.

 
Guangdong Investment: A Good Mix Of Defensiveness And Growth

2017-05-24 seekingalpha
Guangdong Investment holds a portfolio of defensive, cash-flow generative business, including water concessions, toll roads and investment properties that protect investors' downside.

 
Half-year Report

2017-04-24 londonstockexchange
2 FTSE All-World Asia Pacific ex Japan Index (sterling adjusted), for comparison purposes (including dividends reinvested)

 
Director activity falls sharply in value and number for second straight week

2017-02-05 scmp
Bulk of the acquisitions made following the fall in share prices with purchases in Chevalier International, Guangdong Investment Limited, Cosmo Lady (China) Holdings, and Sheen Tai Holdings

 
Final Results

2016-11-10 londonstockexchange
The Company seeks to provide investors with a high level of dividends as well as capital appreciation over the long term, from a diversified portfolio of investments traded on the Pacific, Australasian, Japanese and Indian stock markets ('Asia Pacific region').

 
Water investments - How To Play $1 Trillion Indsutry Like Michael Burry

2016-10-18 valuewalk
Water investments? Michael Burry was one of the first institutional investors to bet against the US subprime mortgage market in the mid-2000s, and today he’s concentrating all of his investment efforts on one commodity: water.

 
3 Funds For Liquid Assets

2016-09-17 seekingalpha
Global water resources are poorly managed, if at all and population growth is creating stresses on existing water resources.

 
China - Invest In Getting Rid Of Pollution - ValueWalk

2016-08-18 valuewalk
China’s pollution problems are well known. A 2015 study linked pollution to nearly 1.6 million deaths each year, or approximately 4,400 deaths per day in the Asian nation. The international non-profit firm WaterAid estimates that nearly 4.5% of China’s population, or 63 million people, do not have access to safe water. When there is a problem, free market systems typically look to provide a solution.

 
The firms being tipped to tap into China’s quest for cleaner water

2016-08-02 scmp
A multi-billion yuan government programme to rid the country of severe water pollution and shortages, offers specialist firms massive opportunities

 
Half-year Report

2016-04-20 londonstockexchange
The Company does not have a formal benchmark. It uses the FTSE All-World Asia Pacific ex Japan Index (sterling adjusted) for reference purposes only.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...